PAR-20-092 - Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3) (Clinical Trial Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

On This Page: 1

Active NOSIs

Title Notice Number Organization Release
Date		 Expiration
Date		 Activity
Code(s)

Expired NOSIs

Title Notice Number Organization Release
Date		 Expiration
Date		 Activity
Code(s)
Notice of Special interest (NOSI): Medications Development for Stimulant Use Disorders NOT-DA-22-049 NIDA Dec 22, 2021 Sep 2, 2022 UG3/UH3
For technical issues E-mail OER Webmaster